TENXHealthcareMicro-Cap
TENAX THERAPEUTICS, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for TENAX THERAPEUTICS, INC. (TENX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are TENX insiders buying or selling?
TENAX THERAPEUTICS, INC. insiders reported 13 open-market buys ($923.2K) and 0 sells ($0) across 13 Form 4 filings — a net buying position of $923.2K.
Source: SEC EDGAR Form 4
Key Statistics (as of Dec 10, 2025)
Total Form 4 filings
13
SEC EDGAR
Insider filers
8
Insider buys (13)
$923.2K
Insider sells (0)
$0
Insider sentiment
Net buyingNet insider flow of $923.2K in net buying.
Recent TENX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 10, 2025 | Rich Stuart | Chief Medical Officer | Purchase | 5.0K | $10.16 | $50.8K |
| Dec 5, 2025 | Rich Stuart | Chief Medical Officer | Purchase | 5.0K | $9.12 | $45.6K |
| Nov 20, 2025 | Christopher Thomas Giordano | CEO | Purchase | 2.6K | $7.68 | $20.0K |
| Nov 20, 2025 | Thomas Mcgauley | Interim CFO | Purchase | 8.0K | $7.27 | $58.2K |
| Nov 19, 2025 | June Sherie Almenoff | Director | Purchase | 2.0K | $7.50 | $14.9K |
| Aug 8, 2024 | PROEHL GERALD T | Director | Purchase | 1.7K | $0.00 | $0 |
| Aug 8, 2024 | Michael H. Davidson | Director | Purchase | 2.5K | $0.00 | $0 |
| Sep 9, 2020 | Steven Boyd | Director, 10% Owner | Purchase | 32.0K | $1.42 | $45.5K |
| Sep 3, 2020 | Steven Boyd | Director, 10% Owner | Purchase | 86.0K | $1.43 | $123.2K |
| Aug 31, 2020 | Steven Boyd | Director, 10% Owner | Purchase | 32.0K | $1.47 | $47.0K |
| Aug 26, 2020 | Steven Boyd | 10% Owner | Purchase | 34.9K | $1.51 | $52.7K |
| Aug 21, 2020 | Steven Boyd | Director, 10% Owner | Purchase | 311.5K | $1.48 | $460.4K |
| May 19, 2020 | Ronald R Blanck | Director | Purchase | 5.0K | $0.95 | $4.8K |
Showing the 13 most recent of 13 Form 4 filings for TENAX THERAPEUTICS, INC..
Most active TENX insiders
- Steven Boyd5 filings
- Rich Stuart2 filings
- Christopher Thomas Giordano1 filing
- June Sherie Almenoff1 filing
- Michael H. Davidson1 filing
Ask anything about TENX insider activity
Use Trabud's AI agent to query TENAX THERAPEUTICS, INC.'s Form 4 history in plain English — "Show me TENX CEO purchases this year" or compare it against any other ticker.
Open the AI agentTENX insider trading FAQ
Are TENAX THERAPEUTICS, INC. insiders buying or selling?
Across 13 SEC Form 4 filings, TENAX THERAPEUTICS, INC. (TENX) insiders reported 13 open-market purchases totaling $923.2K and 0 sales totaling $0. That is a net buying position of $923.2K.
How many insiders trade TENX stock?
8 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for TENAX THERAPEUTICS, INC.. The most recent filing was accepted on Dec 10, 2025.
Where does Trabud get TENX insider trading data?
All TENX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.